We are live on !
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
Turnover
15.26%
1-Year Est. Return
41.24%
This Quarter Est. Return
+25.64%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$69.2B
AUM Growth
+$1.61B
(+2.4%)
Cap. Flow
-$7.07B
Cap. Flow % of AUM
Cap. Flow %
-10.23%
Top 10 Holdings %
Top 10 Hldgs %
46.63%
Holding
2,045
New
180
Increased
582
Reduced
1,148
Closed
132
Avg Time Held
6.4
years
Top 10 Avg Time Held
5.6
years
Top 20 Avg Time Held
5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$199M |
| 2 |
Sandisk
SNDK
|
+$197M |
| 3 |
Genuine Parts
GPC
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$134M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$76.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares GENIUS Money Market ETF
IQMM
|
+$876M |
| 2 |
NVIDIA
NVDA
|
+$678M |
| 3 |
Apple
AAPL
|
+$472M |
| 4 |
Microsoft
MSFT
|
+$341M |
| 5 |
Micron Technology
MU
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.21% |
| 2 | Miscellaneous | 27.25% |
| 3 | Industrials | 6.93% |
| 4 | Consumer Staples | 6.67% |
| 5 | Consumer Discretionary | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1851
The Honest Company
HNST
$494M
| $46.1K | ﹤0.01% |
12,593
-1,136
| -8% | -$3.83K |
2024 Q3
7 quarters
|
|
1852
Clean Energy Fuels
CLNE
$309M
| $44.1K | ﹤0.01% |
21,519
-3,685
| -15% | -$7.83K |
2020 Q2
24 quarters
|
|
1853
DELISTED
Open Lending Corp
LPRO
| $42.6K | ﹤0.01% |
13,684
-978
| -7% | -$2K |
2021 Q2
20 quarters
|
|
1854
Bumble
BMBL
$799M
| $42.5K | ﹤0.01% |
13,271
+2,845
| +27% | +$9.7K |
2022 Q2
16 quarters
|
|
1855
Hertz
HTZ
$684M
| $41.5K | ﹤0.01% |
18,314
-343
| -2% | -$1.87K |
2024 Q3
7 quarters
|
|
1856
Blend Labs
BLND
$272M
| $41.3K | ﹤0.01% |
24,127
-4,480
| -16% | -$7.15K |
2024 Q3
7 quarters
|
|
1857
B&G Foods
BGS
$167M
| $41K | ﹤0.01% |
10,304
-1,006
| -9% | -$4.66K |
2022 Q4
14 quarters
|
|
1858
W&T Offshore
WTI
$629M
| $40.4K | ﹤0.01% |
12,823
-1,569
| -11% | -$5.82K |
2020 Q2
24 quarters
|
|
1859
Palisade Bio
PALI
$202M
| $40.4K | ﹤0.01% |
+19,325
| New | +$38K |
2026 Q2
0 quarters
|
|
1860
Verastem
VSTM
$1.23B
| $39.9K | ﹤0.01% |
+10,457
| New | +$50.6K |
2026 Q2
0 quarters
|
|
1861
Eledon Pharmaceuticals
ELDN
$202M
| $39.7K | ﹤0.01% |
10,086
-746
| -7% | -$2.71K |
2025 Q4
2 quarters
|
|
1862
Century Therapeutics
IPSC
$264M
| $39.5K | ﹤0.01% |
+16,137
| New | +$36.9K |
2026 Q2
0 quarters
|
|
1863
Anavex Life Sciences
AVXL
$118M
| $39.1K | ﹤0.01% |
15,109
-1,720
| -10% | -$5.09K |
2021 Q4
18 quarters
|
|
1864
DELISTED
Olaplex Holdings
OLPX
| $38.6K | ﹤0.01% |
18,853
-1,514
| -7% | -$3.09K |
2024 Q3
7 quarters
|
|
1865
Akebia Therapeutics
AKBA
$193M
| $38.6K | ﹤0.01% |
33,836
-2,868
| -8% | -$3.41K |
2024 Q3
7 quarters
|
|
1866
Alvotech
ALVO
$1.74B
| $37.8K | ﹤0.01% |
10,233
-4,543
| -31% | -$16.2K |
2025 Q3
3 quarters
|
|
1867
Compass Therapeutics
CMPX
$133M
| $37.6K | ﹤0.01% |
17,167
-1,536
| -8% | -$4.54K |
2023 Q2
12 quarters
|
|
1868
N-able
NABL
$975M
| $37.6K | ﹤0.01% |
10,232
-871
| -8% | -$3.62K |
2023 Q2
12 quarters
|
|
1869
Krispy Kreme
DNUT
$524M
| $37.2K | ﹤0.01% |
10,534
-650
| -6% | -$2.32K |
2023 Q2
12 quarters
|
|
1870
Real REMAX Group Inc. Common Stock
REAX
$320M
| $37.2K | ﹤0.01% |
2,043
-6
| -0.3% | -$122 |
2024 Q3
7 quarters
|
|
1871
Larimar Therapeutics
LRMR
$262M
| $37K | ﹤0.01% |
12,125
+425
| +4% | +$1.69K |
2024 Q4
6 quarters
|
|
1872
Virgin Galactic
SPCE
$403M
| $36.6K | ﹤0.01% |
+12,650
| New | +$41.3K |
2026 Q2
0 quarters
|
|
1873
Vista Gold
VGZ
$380M
| $36.1K | ﹤0.01% |
+18,925
| New | +$41.3K |
2026 Q2
0 quarters
|
|
1874
EVgo
EVGO
$170M
| $34.1K | ﹤0.01% |
17,873
-942
| -5% | -$1.9K |
2023 Q3
11 quarters
|
|
1875
enCore Energy
EU
$147M
| $33.4K | ﹤0.01% |
25,531
-1,166
| -4% | -$1.96K |
2023 Q2
12 quarters
|
|
Similar funds
ProShare Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, ProShare Advisors held 2,045 positions worth $69.2B, up 2.4% from $67.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
ProShare Advisors withdrew a net $7.07B in Q2 2026, closing 132 positions and reducing 1,148 holdings. Its most notable exit was Atlassian, an estimated $14.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Industrials.
Against the trend, ProShare Advisors opened a new position in Honeywell Aerospace worth $76.5M.
- ProShare Advisors's largest Q2 2026 buy was Honeywell Aerospace: 346,243 shares worth $76.5M.
- ProShare Advisors added most to General Dynamics in Q2 2026, an estimated $199M increase.
- ProShare Advisors's biggest Q2 2026 reduction was ProShares GENIUS Money Market ETF, cutting an estimated $876M.
- ProShare Advisors fully exited Atlassian in Q2 2026, selling an estimated $14.7M.
- ProShare Advisors's ten largest holdings make up 47% of its $69.2B portfolio in Q2 2026.
- ProShare Advisors opened 180 new positions and closed 132 in Q2 2026.
- ProShare Advisors's portfolio value rose 2.4% quarter-over-quarter to $69.2B.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.